Save up -80% on Tacrolimus
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Prograf
|$39.23||120 capsules/1 mg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Tacrolimus coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Tacrolimus every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Tacrolimus volume of distribution
* 2.6 2.1 L/kg (pediatric liver transplant patients) * 1.07 0.20 L/kg (patients with renal impairment, 0.02 mg/kg/4 hr dose, IV) * 3.1 1.6 L/kg (Mild Hepatic Impairment, 0.02 mg/kg/4 hr dose, IV) * 3.7 4.7 L/kg (Mild Hepatic Impairment, 7.7 mg dose, PO) * 3.9 1.0 L/kg (Severe hepatic impairment, 0.02 mg/kg/4 hr dose, IV) * 3.1 3.4 L/kg (Severe hepatic impairment, 8 mg dose, PO)
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Tacrolimus
Tacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient’s immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants, and the skin condition vitiligo. It was discovered in 1984 from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. Tacrolimus is chemically known as a macrolide. It reduces peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP-12 (FK506 binding protein) creating a new complex. This FKBP12-FK506 complex interacts with and inhibits calcineurin thus inhibiting both T-lymphocyte signal transduction and IL-2 transcription.
Tacrolimus mechanism of action
The mechanism of action of tacrolimus in atopic dermatitis is not known. While the following have been observed, the clinical significance of these observations in atopic dermatitis is not known. It has been demonstrated that tacrolimus inhibits T-lymphocyte activation by first binding to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin is then formed and the phosphatase activity of calcineurin is inhibited. This prevents the dephosphorylation and translocation of nuclear factor of activated T-cells (NF-AT), a nuclear component thought to initiate gene transcription for the formation of lymphokines. Tacrolimus also inhibits the transcription for genes which encode IL-3, IL-4, IL-5, GM-CSF, and TNF-, all of which are involved in the early stages of T-cell activation. Additionally, tacrolimus has been shown to inhibit the release of pre-formed mediators from skin mast cells and basophils, and to downregulate the expression of FceRI on Langerhans cells.
Dosage forms of Tacrolimus
|Capsule (extended release)||oral||0.5 mg|
|Capsule (extended release)||oral||1 mg|
|Capsule (extended release)||oral||3 mg|
Anhydrous tacrolimus Tacrolimus anhydrous
Accord Healthcare Inc
Humans and other mammals
Indication of Tacrolimus
For use after allogenic organ transplant to reduce the activity of the patient’s immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Tacrolimus on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.